Key result
In patients who developed persistent atrial flutter during antiarrhythmic treatment for atrial fibrillation, radiofrequency ablation and continued pharmacologic therapy maintained sinus rhythm in 93%.
Why the study?
Does radiofrequency ablation combined with continued antiarrhythmic therapy maintain sinus rhythm in patients who develop persistent atrial flutter while treated for atrial fibrillation?
Cohort (n=136)
Does radiofrequency ablation combined with continued antiarrhythmic therapy maintain sinus rhythm in patients who develop persistent atrial flutter while treated for atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Radiofrequency ablation of the cavotricuspid isthmus allows safe and effective maintenance of sinus rhythm in patients who develop typical atrial flutter while on antiarrhythmic drugs for atrial fibrillation.
INTRODUCTION: Antiarrhythmic drugs have been reported to promote the conversion of atrial fibrillation to atrial flutter in patients with paroxysmal atrial fibrillation. However, information about the electrophysiologic mechanism and response to radiofrequency ablation of these drug-induced atrial flutters is limited. Furthermore, the determinants of the development of persistent atrial flutter in patients treated for atrial fibrillation with antiarrhythmic drugs are still unknown. METHODS AND RESULTS: Among the 136 patients treated for atrial fibrillation with amiodarone (n = 96) or propafenone (n = 40), 15 (11%, mean age 65.5 +/- 12.3 years) were identified to have subsequent development of persistent atrial flutter based on surface ECG characteristics during antiarrhythmic drug treatment. The mean interval between the beginning of drug treatment and the onset of atrial flutter was 5.0 +/- 5.5 months. Intracardiac mapping and entrainment studies revealed that 11 patients had counterclockwise typical atrial flutter, and 4 had clockwise typical atrial flutter. All 15 patients underwent successful ablation with creation of complete bidirectional isthmus conduction block. After a mean follow-up of 12.3 +/- 4.2 months, 14 (93%) of 15 patients who underwent successful ablation and continued taking antiarrhythmic drugs have remained in sinus rhythm. Univariate analysis of clinical variables demonstrated that only atrial enlargement was significantly related to the occurrence of persistent atrial flutter. CONCLUSION: In patients with atrial fibrillation, persistent typical atrial flutter might occur during antiarrhythmic drug treatment, and atrial enlargement was a risk factor for the development of such an arrhythmia. Radiofrequency ablation and continuation of pharmacologic therapy offered a safe and effective means of achieving and maintaining sinus rhythm.
No takes yet. Share an insight, caveat, or question.
TAI et al. (1999) conducted a cohort in Atrial fibrillation (n=136). Amiodarone or propafenone therapy and subsequent radiofrequency ablation was evaluated on Maintenance of sinus rhythm after successful ablation. In patients who developed persistent atrial flutter during antiarrhythmic treatment for atrial fibrillation, radiofrequency ablation and continued pharmacologic therapy maintained sinus rhythm in 93%.
Synapse has enriched 10 related papers. Consider them for comparative context: